Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluating the prognostic potential of circulating cell-free DNA in advanced thyroid cancer.

Endocrine-related cancer - 1 Feb 2025

Wijewardene Ayanthi, Clifton-Bligh Roderick J, Wang Bin, Luxford Catherine, Robinson Bruce G, Bullock Martyn, Gild Matti

Abstract excerpt

Liquid biopsies are a minimally invasive approach to obtain biomarkers including cell-free DNA (cfDNA) from peripheral blood. To date, there are limited and conflicting studies evaluating their role in thyroid cancer. Our study evaluated the utility of cfDNA in advanced thyroid cancers. Patients aged >18 years with metastatic medullary thyroid cancer (MTC), poorly differentiated thyroid cancer (PDTC) or...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Biomarkers, Tumor

Share to Cell-Free Nucleic Acids

Share to Mutation

Share to Prognosis

Share to Thyroid Neoplasms

Source

Identifiers

PMID: 39602340
DOI: 10.1530/ERC-24-0227

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluating the prognostic potential of circulating cell-free DNA in advanced thyroid cancer.PMID 39602340Read ↗

Characterization of the Thyroid Cancer Genomic Landscape by Plasma-Based Circulating Tumor DNA Next-Generation Sequencing.Semantic proximity Read ↗

Clinical Utility of Circulating Cell-Free DNA Mutations in Anaplastic Thyroid Carcinoma.Semantic proximity Read ↗

Diagnostic value of cell-free DNA in thyroid cancer: A systematic review and meta-analysis.Semantic proximity Read ↗

Tumor-informed liquid biopsy for monitoring thyroid cancer: a proof-of-concept study.Semantic proximity Read ↗

Real-Time Genomic Characterization Utilizing Circulating Cell-Free DNA in Patients with Anaplastic Thyroid Carcinoma.Semantic proximity Read ↗

Diagnostic and prognostic value of circulating tumor-related DNA in cancer patients.Semantic proximity Read ↗

Cell-free DNA as a biomarker in cancerSemantic proximity Read ↗

CirculatingBRAFV600E Cell-Free DNA as a Biomarker in the Management of Anaplastic Thyroid CarcinomaSemantic proximity Read ↗

Cell-free DNA methylation biomarker for the diagnosis of papillary thyroid carcinomaSemantic proximity Read ↗

Plasma cell-free DNA (cfDNA) assays for early multi-cancer detection: The circulating cell-free genome atlas (CCGA) studySemantic proximity Read ↗

Molecular predictive biomarker testing in advanced thyroid cancer - a European consensus.Semantic proximity Read ↗

Challenges in Using ctDNA to Achieve Early Detection of CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.